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ABSTRACT 
Chronic spine pain poses a peculiar diagnostic and therapeutic challenge due to multiple pain sources, overlapping 
clinical features and nonspecific radiological findings. Facet joint injection is an interventional pain management tool for 
facet-related spinal pain that can be effectively administered by a radiologist. This technique is the gold standard for 
identifying facet joints as the source of spinal pain. The major indications for facet injections include strong clinical 
suspicion of the facet syndrome, focal tenderness over the facet joints, low back pain with normal radiological findings, 
post-laminectomy syndrome with no evidence of arachnoiditis or recurrent disc disease, and persistent low back pain 
after spinal fusion. The contraindications are more ancillary, with none being absolute. Like any synovial joint 
degeneration, inflammation and injury can lead to pain on motion, initiating a vicious cycle of physical deconditioning, 
irritation of facet innervations and muscle spasm. Image-guided injection of local anesthetic and steroid into or around 
the facet joint aims to break this vicious cycle and thereby provide pain relief. This outpatient procedure has high 
diagnostic accuracy, safety and reproducibility but the therapeutic outcome is variable. © 2011 Biomedical Imaging and 
Intervention Journal. All rights reserved. 
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INTRODUCTION 
The spine is the most common source of chronic 
pain [1] and the second most common reason for a 
patient to consult a physician [2]. About two-thirds of the 
population suffers from back pain at some point of time 
during their life span [2] and this symptom incapacitates 
20% of them for long periods (>4 weeks) [3]. Chronic 
back pain entails suffering and disability of considerable 
ergonomic significance, since the majority afflicted by 
this malaise belongs to the age group of 30–50 years [4]; 
this implies loss of precious man-hours. The incidence of 
chronic spine pain is at least 5% annually [5–7], with the 
average prevalence in adults being 15% [8, 9]. 
Notwithstanding the fact that duration of pain and its 
chronicity are controversial topics with poor universal 
consensus on the definition, pain that continues for more 
than 7–12 weeks despite conservative management is 
generally accepted as chronic [4]. Traditionally, it has 
been believed that most episodes of spinal pain will be 
short-lived and that 90% of patients recover in about six 
weeks with or without treatment, and hence it is best 
managed conservatively, with rest, physiotherapy and 
analgesics/muscle relaxants [5, 6, 10, 11]. However, 
several studies have dispelled this belief and shown that 
chronicity or recurrence of low back pain ranges from 
28% to 75% [10, 12–17]. This statistical detail warrants 
the allopaths to have a keener look at remedies for 
chronic spinal pain. 
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Figure 1 Diagrammatic representation of facet joint anatomy. 
In most instances, spinal symptoms are due to a 
benign non-emergent condition involving some degree of 
spinal degeneration. Unfortunately in most cases, 
imaging abnormalities do not correlate with clinical 
symptoms [18–20]. It is not unusual to encounter an 
asymptomatic individual with striking abnormalities at 
imaging [19, 20] and patients with incapacitating 
symptoms but normal CT and MR findings [18]. The 
association between symptoms and imaging findings is 
weak as imaging studies are only able to identify a cause 
for spinal pain in just 15% of patients with chronic back 
pain [2, 21]. Hence many patients do not receive a 
specific diagnosis and continue to suffer pain. In such 
patients, spinal injections allow a functional assessment 
of the anatomical structures that could potentially be the 
culprit. Diagnostic spinal injections can identify the 
source of pain, and may be followed by therapeutic 
injections with a mixture of a long-acting local 
anaesthetic and depot steroid preparations, if relevant. 
For an anatomical structure to be deemed as a 
potential cause of pain, it must fulfil four criteria: a) it 
must have a nerve supply; b) it should be capable of 
causing pain similar to that seen clinically in normal 
volunteers; c) it must be susceptible to painful diseases 
or injuries; and d) using diagnostic techniques of known 
reliability and validity, the structure must be 
demonstrated as a source of pain in patients [22]. Going 
by these postulates, structures that may cause spinal pain 
include the vertebral body, inter-vertebral discs, the 
spinal cord, nerve roots, facet joints, ligaments, muscles, 
and sacroiliac or atlanto-axial and atlanto-occipital joints. 
Among these, a radiologist often addresses the following 
3 major conditions: (a) disc disease, (b) facet syndrome, 
and (c) vertebral body disease [23]. Facet joints were 
proven to be the culprit in 15% to 45% of patients with 
low back pain [24–29], 54–67% of patients with neck 
pain [30–32], and 48% of patients with thoracic pain [8]. 
In short, facet joint is a common cause for chronic pain 
and this review aims to emphasise on various aspects of 
imaging-guided intra-articular injection into the facet 
joint as a diagnostic and therapeutic tool. 
HISTORICAL BACKGROUND 
An imaging-guided technique with fluoroscopy or 
computed tomography (CT) increases the precision of 
spinal injection procedures and confirms the needle 
placement. Since they give better results and reduce 
complications, they are now preferred over blind 
injections. Goldthwait [33] in 1911 first described 
lumbar facet joints as a source of back pain, and this was 
further endorsed by the writings of Putti [34], an Italian 
surgeon, in 1927. Subsequently, in 1933, Ghormley [35] 
coined the term facet syndrome and defined it as a 
lumbosacral pain (with or without sciatic pain) that 
suddenly occurs after a twisting or rotary strain to the 
lumbosacral spine. In 1941, Badgley [36] suggested that Peh Biomed Imaging Interv J 2011; 7(1):e4   3 
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Figure 2 This line diagram demonstrates the dual nerve supply of the facets. Note the dorsal branches (shown by arrows) 
supplying the facet joint at the level of its exit and the subsequent lower one. 
 
facet joints could be a primary source of pain separate 
from the nerve compression component and 
demonstrated that facet joint pathology could cause 
symptoms, including radiation of pain into the lower 
extremities. However, it was only in 1963 that Hirsch et 
al. [37] injected hypertonic saline into facet joints and 
experimentally reproduced low back pain along the 
sacroiliac and gluteal areas with radiation to the greater 
trochanter. In 1976, Mooney and Robertson [38], 
followed by McCall et al. (39) in 1979, used fluoroscopic 
guidance for facet joint injection with steroids and local 
anaesthetics. 
FACET JOINT ANATOMY [22, 37, 40–52] 
The facet joints are paired diarthrodial articulations 
located between the posterior elements of the adjacent 
vertebrae; also known as zygo-apophyseal joints. They 
are formed by the articulation of the inferior articular 
processes of one vertebra with the superior articular 
processes of the vertebra below (Figure 1) [40]. They are 
typical synovial joints with the facets covered by 
articular cartilage, bridging synovial membrane, tough 
fibrous capsule and intervening layer of loose areolar 
tissue. On the ventral aspect, the capsule is deficient and 
the joint is in contact with the ligamentum flavum. The 
joint capsule is redundant along the superior and inferior 
aspects, forming the respective recesses which are filled 
with small synovial villi or fat pads approximately the 
size of rice grains [41]. Adipose tissue contained within 
the superior recess is continuous with that around the 
spinal nerve [37]. The facet joints are asymmetric in 
30 % of the population [43]. 
The facet joints are richly innervated by the nerve 
fibres from the medial branch of the dorsal ramus of 
spinal nerves. Each facet has a dual nerve supply 
(Figure 2), from the dorsal ramus at the same level as 
well as from the level above. Each spinal nerve root 
innervates two facets; it supplies the facet joint at the 
level it exits, as well as the subsequent lower facet. The 
exceptions to this dual nerve supply are: singular nerve 
supply to the atlanto-occipital joint, atlanto-axial joint 
and C2/3 facet joint, which are innervated by C1, C2 and 
C3 nerves respectively [51,52]. Histological studies have 
shown that capsules of the facet joints are richly 
innervated with free nerve endings [37, 22]. This means 
that they are endowed with the appropriate sensory 
apparatus to transmit proprioceptive and nociceptive 
information. 
The facet joints are anatomically designed to 
restrain excessive mobility and distribute axial loading 
over a broad area. The variation in their shapes and their 
orientation prevents forward displacement and rotatory 
dislocation of the intervertebral joint. The articular 
processes do provide a sliding surface for some 
movements, with roughly 5 to 7 mm of motion possible 
along the plane of the joint [43]. The cervical facet joints 
are typically oriented in an oblique coronal plane, angled 
superior to inferior in a posterior direction. The thoracic 
facet joints are nearly vertical and coronal in orientation, 
rotating towards the sagittal plane near the 
thoracolumbar junction. The superior lumbar facet joints 
are oriented in a nearly sagittal plane, and the plane of 
orientation rotates outward towards the coronal plane 
with descent in the lumbar spine so that the joints are in a 
sagittal-coronal oblique plane at the lumbosacral junction 
(Figure 3). Familiarity with the orientation of the joints is 
important in selecting an appropriate approach for 
advancing the needle during facet joint injections. Peh Biomed Imaging Interv J 2011; 7(1):e4   4 
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Figure 3 This ceramic model of the spine shows the gradual change in the orientation of the facets. Note the obliquity at which 
the L3/L4 joint space is seen in profile while the rest of the facet joints are out of profile. It is evident that, starting from 
a prone position, the upper lumbar facet joints (near sagittal) will be seen in profile at lesser angles of rotation than the 
lower lumbar facets (near coronal). 
 
PATHOPHYSIOLOGY OF THE FACET SYNDROME 
Pain of facet joint origin is attributed to a variety of 
causes, including: segmental instability, synovitis, 
synovial entrapment, trauma, meniscoid impingement, 
chondromalacia and osteoarthritis [18, 53–55]. The 
earlier described synovial villi within the facet joints 
may become inflamed or trapped between the articular 
processes, thereby producing pain [40]. Distension and 
inflammation of the synovial capsule, with resultant 
stimulation of the nociceptive nerve endings [56] and 
expanded synovial recesses compressing the nerve roots 
in the spinal canal and neural foramina, thereby causing 
radiculopathy in patients with facet syndrome [56, 57], 
are among the other theories on the subject. Irrespective 
of the mechanism, degeneration, inflammation and injury 
of facet joints can lead to pain upon joint motion. This 
pain leads to restriction of motion, and eventual physical 
deconditioning. Irritation of the facet joint innervations 
can also result in muscle spasm. Pain innervations are 
also present in other local soft tissue structures adjacent 
to the joint including the multifidus, the local spinal 
nerves, and the dura and epidural space. Joint 
inflammation may cause localised hyperemia and venous 
stasis, thus affecting other local tissues [44]. Thus, a self-
perpetuating painful mechanism is set into motion. 
Certain studies have proposed disc degeneration to 
initiate degenerative changes in the facet joints by 
altering the bio-mechanics of the entire motion segment 
[58, 59]. Numerous other causes like rheumatoid arthritis, 
ankylosing spondylitis and capsular tears, have also been 
described as causes of facet joint pain [22]. Radiographic 
changes of osteoarthritis are equally common in patients 
with and without low back pain, and degenerative joints 
seen on CT are not always painful, although some 
researchers claim that severely degenerated joints are 
more likely to be symptomatic (19, 22, 60, 61). 
INDICATIONS FOR FACET INJECTION 
Imaging findings are of little help in diagnosing the 
facet syndrome. It is usually a diagnosis of exclusion that 
is arrived at, after excluding mimics like nerve 
entrapment syndrome, discogenic pain, spinal stenosis 
and osseous abnormalities. In patients with facet joint 
syndrome, distension of the joint with saline or contrast 
will reproduce the pain, and injection of a local 
anaesthetic agent will relieve the pain [62, 63]. This 
response pattern is the current gold standard for 
diagnosing the facet syndrome [38, 60, 61, 64–66]. 
Provocation of pain from a joint injection is an unreliable Peh Biomed Imaging Interv J 2011; 7(1):e4   5 
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criterion, but relief of pain is a prima facie evidence for 
making the diagnosis [22] The diagnostic injection 
permits testing of the hypothesis that the target structure 
(facet joint) is the source of a patient’s pain. Revel et al. 
[67] found that clinical signs are unsuitable for making a 
diagnosis, but may be of value in selecting patients for 
diagnostic block of the facet joint. Hence, the 
interventional/musculoskeletal radiologist and 
rheumatologist/spine specialist will need to work in close 
consultation to select the appropriate candidate for facet 
injection. 
Indications may be classified as: (a) diagnostic and 
(b) therapeutic. 
Diagnostic 
1.  The primary indication is to confirm a clinical 
suspicion of the facet syndrome. Clinical signs 
include local paraspinal tenderness; pain that is 
brought about or increased on hyperextension, 
rotation, and lateral bending; absence of 
neurologic deficit; absence of root tension signs; 
and hip, buttock, or back pain when the straight 
leg is raised [53]. Symptoms of facet syndrome 
also include cramping leg pain involving the thigh 
but not radiating below the knee, low back 
stiffness, and absence of paraesthesia [53]. The 
back stiffness is typically most marked in the 
morning [68]. Low back pain is brought about or 
increased by maintenance of certain positions, 
such as sitting erect for a long period of time [69]. 
Focal tenderness over a facet joint is a strong 
indication in the appropriate settings, besides the 
presence of signs of paravertebral spasm or 
deformity in patients, with abnormal facet joints 
on imaging studies [61]. Cervical facet pain is 
often characterised by chronic headaches, 
restricted motion and axial neck pain, which may 
radiate sub-occipitally to the shoulders or mid-
back [70]. 
2.  Multilevel spinal involvement in a chronic pain 
process after excluding other obvious causes, 
conflict between the location of imaging 
abnormalities and clinical symptoms, and for pre-
surgical testing [66]. 
3.  Chronic low back pain (lumbar facets) and chronic 
neck pain (cervical facets) that are not relieved by 
trial of routine non-steroidal anti-inflammatory 
drugs (NSAIDs) and physiotherapy. 
4.  Post-laminectomy syndrome with no evidence of 
arachnoiditis or recurrent disc disease [18]. 
5.  Persistent low back pain after a stable 
posterolateral fusion [63]. 
6.  Post-whiplash injury, chronic neck pain [70]. 
7.  Low back pain, with or without sciatica, but with 
normal radiological findings [63, 69]. 
Therapeutic 
1.  Patients with confirmed facet syndrome especially 
those who respond to diagnostic facet injection. 
2.  As an adjunct to conservative management. 
3.  In patients on oral or systemic drug therapy if 
these drugs have to be discontinued because of 
their adverse effects or if they have reached their 
maximum tolerable dose. 
4.  Presence of adjacent segment deterioration after 
spinal fusion [66]. 
5.  Pain due to attrition across spondylolytic defects 
[18, 69]. 
CONTRAINDICATIONS [55, 56] 
Exclusion criteria are relative with no absolute 
contraindications. Injections are generally avoided in 
patients with: systemic infection or skin infection over 
puncture site; bleeding disorders or coagulopathy; 
allergy to contrast agents or any of the medications to be 
administered; inability to obtain percutaneous access to 
the target facet joint; progressive neurological disorder 
which may be masked by the procedure; and pregnancy. 
TECHNIQUE, DRUGS AND EQUIPMENT 
The procedure is usually done on an outpatient basis. 
Before the start of the procedure, the patient should be 
interviewed about the type, location and nature of the 
pain, and any history of prior surgery. Pain drawings 
may be helpful in identifying the specific levels that are 
associated with the patient’s complaints. The patient’s 
medical and imaging records should be carefully 
reviewed, and the magnetic resonance (MR) images 
should be compared with radiographs to evaluate for 
possible level ambiguity due to a transitional 
lumbosacral segment. When obtaining an informed 
consent, ensure that the patient understands the purpose 
of the procedure, the risks involved and most importantly, 
are enlightened about the variable therapeutic outcomes. 
The patient needs to be aware that unlike most of the 
other therapeutic interventions, the outcome of this 
procedure is highly variable and they may not receive the 
desired benefit. Similarly, they must be aware of the 
transient nature of the therapeutic benefits and there may 
be a need for repeated injections. In the author’s practice, 
the patient comes fasting for 6 to 8 hours prior to the 
procedure. Although premedication is not routinely used, 
a mild sedative may be administered in anxious patients. 
Sedation is avoided as far as possible, since it may 
interfere with the patient’s response to pain reproduction. 
The procedure is performed with strict aseptic 
precautions and intra-procedural regular monitoring of 
the vital parameters is recommended. Facet joint 
injection is best performed in an interventional suite 
within the diagnostic radiology department. High-quality 
C-arm fluoroscopy is preferred. The type of image 
guidance used for facet injection is a matter of personal 
preference and depends on the expertise of the operator. 
In the personal experience of the author, the procedure 
time is shorter for fluoroscopy-guided injections and 
radiation exposure is also lower. Alternatively, Peh Biomed Imaging Interv J 2011; 7(1):e4   6 
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Figure 4 Left-sided L3/L4 facet joint is seen in profile (arrows). Also note the needle seen end-on within the ipsilateral L4/L5 facet 
joint. 
 
ultrasound, CT and MR guidance may also be used for 
the needle placement. 
The facet joint injection set that is used in the 
author’s institute consists of: a 23G spinal needle for 
entering the facet joint; a 18G needle for aspirating drugs; 
a 24G hypodermic needle for skin infiltration with 
lignocaine; a 1ml insulin syringe for delivering the 
injectate into the joint; 40mg% Triamcinolone (a long-
acting steroid depot preparation) and 0.5% Bupivacaine 
(long-acting local anaesthetic agent). The local 
anaesthetic and steroid were mixed in equal volumes. 
The local anaesthetic used here should be preservative-
free, so as to prevent flocculation of the steroid. Other 
steroids like methyprednisolone or betametasone may be 
employed. 1% Lignocaine is used for skin infiltration, 
and 300 mg% Iohexol as the contrast agent. In the 
majority of cases, anatomical location of the needle tip 
on fluoroscopic imaging is sufficient for localisation. 
Contrast arthrography is not performed in all the patients 
since the author’s practice does not insist on precise 
intra-articular injection. From anecdotal experience, 
periarticular injections give equivalent results as 
endorsed by certain published studies [39, 71, 72]. In 
thick patients, a longer spinal needle may be required. In 
some instances, even co-axial insertion of the spinal 
needle through an 18 or 20 G stiff metallic needle (with 
stillete) may be required, as manipulation of the spinal 
needle through a thick layer of muscle and fat may not be 
always possible. 
The biggest problem is the initial clinical 
determination of those patients who may have facet 
syndrome and the decision as to which level(s) to inject. 
Hence, multiple injections are often required. The local 
anaesthetic agent within the injectate may act on the 
nociceptive fibres in the synovium, whereas intracapsular 
corticosteroids may reduce inflammation of the 
synovium [63]. In such targeted injections, the 
anaesthetic is probably responsible for immediate pain 
relief, whereas steroids are believed to be responsible for 
pain relief 2–6 days after their administration [73]. For a 
diagnostic block, a short-acting anaesthetic alone may be 
sufficient. A long-acting agent like bupivacaine is 
preferred for therapeutic injections since it has an added 
advantage of prolonging the nerve conduction blockage 
of the nociceptive fibres, thereby breaking the pain cycle 
for longer durations [54]. Presumably, if this interruption 
of the pain cycle is of adequate duration, the natural 
mechanisms may overcome or compensate for the cause 
of pain, and the patient may yield better therapeutic 
results. The role of steroids is controversial, with some 
studies showing no advantage from the addition of 
steroids to the injectate [74]. However, it is advisable to 
follow the recommendation on the upper limit of steroid 
usage (3mg/kg of body weight of steroid, or 210mg per 
year in an average person and a lifetime dose of 420 mg 
of steroid, equivalent to methylprednisolone) [75]. In the 
diagnostic phase, a patient may receive injections at 
intervals of no less than one, week, though a two–week 
interval is preferable. In the therapeutic phase, the 
suggested interval between injections is two months, 
provided that at least > 50% relief is obtained for 6 
weeks [75]. 
LUMBAR INTRA-ARTICULAR FACET INJECTIONS 
(FIGURES 2, 3, 4) 
Patient lies prone and centering is done at the spinal 
level of interest. 
The patient is made to turn gently so that the side to 
be injected is raised off the couch, till the joint is seen in 
profile (Figure  4). This position is now secured. 
Alternatively, the tube may be tilted to obtain an 
equivalent projection of the facet. 
The facet joints are curved structures. The superior 
facets face anterolaterally while the inferior facets face 
posteromedially. Hence, the posterior aspect of the joint 
lies further from the midline than the anterior aspect [42, Peh Biomed Imaging Interv J 2011; 7(1):e4   7 
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76]. During postero-anterior fluoroscopy, as we gently 
rotate the patient through an arc, the first portion of the 
joint seen is its posterior aspect. Over-rotation may bring 
the anterior portion of the joint in profile. This has to be 
avoided since seeing the anterior joint margin in profile 
will make needle placement into the joint impossible. 
The upper lumbar spine may require obliquity of as little 
as 30 degrees, while the lower lumbar spine may require 
obliquity of up to 60 degrees (Figure 3). Once localised, 
the needle may be to be directed vertically into the centre 
of the facet joint space. 
Alternatively, one may also use the technique 
described by Sarazin et al. [61]. They perform the 
procedure with the patient prone, and the needle is 
advanced towards the lower pole of the inferior 
apophyseal process, as this is the expected location of the 
inferior recess of the facet joint. The inferior recess is 
preferentially targeted since it is located posteriorly, has 
no direct relation with neural elements, is relatively 
capacious and is easy to enter. This approach is more 
useful in the presence of obstructing osteophytes. In a 
kyphotic posture, this space widens, hence pillows may 
be placed below the abdomen to generate kyphosis. If the 
spine is osteoporotic and the inferior apophyseal process 
is not seen well, the target point is located at the medial 
projection of the vertebral pedicle. 
Once the site for entry is selected, the skin is marked 
at this position and local anaesthetic infiltrated into the 
skin and superficial muscles. The spinal needle is then 
inserted vertically through this point until it reaches the 
bone. Once it enters the joint, a “giving way” sensation is 
perceived. Some minor manipulation may be needed to 
get into the joint space. 
The intra-articular location of the needle tip is be 
confirmed by rotating the patient and observing the 
needle tip move together with the facet joint. 
Alternatively, a facet arthrogram may be done. If the 
needle tip is intra-articular in position, the contrast flows 
away from the needle tip during injection [69], extending 
into the superior aspect of the facet joint or opacifying 
one of the recesses located in a dependent part of the 
joint capsule. Usually no more than 0.2 ml of contrast is 
injected, as it can restrict the amount of drug mixture that 
has to be injected later. The joint capsule is smooth and 
oval in the frontal projection and S-shaped in the oblique 
projection. If the contrast agent accumulates as a blob, 
the needle is likely to be at the wrong site; do not inject 
more as it can smudge the field. In the lumbar spine, the 
arthrogram can often show variable pictures, with the 
contrast agent sometimes going into the contralateral 
facet and sometimes into the facet joint above. If there is 
spondylolysis, the defect in the part interarticularis may 
be opacified [77]. A positive block is useful in the 
diagnosis of pars defect-related pain, particularly when 
spinal fusion surgery is being considered. 
Once the position of the needle tip is confirmed, a 
combination consisting of 1 to 1.5 ml of the steroid and 
local anaesthetic, in equal parts, is injected. Always 
aspirate before injection, to exclude accidental 
intravascular location of needle. The volume of the joint 
usually does not exceed 1.5 to 2ml. We usually terminate 
the injection when resistance is encountered. Large 
volume injections may cause rupture of the joint capsule 
and extravasation of the injectate into the epidural space; 
this may account for part of the therapeutic effect 
described in certain studies [78]. 
Periarticular injection is an acceptable alternative, 
should reasonable attempts to gain an intra-articular 
position prove difficult. During a periarticular injection, 
the needle is rotated 360 degrees at the desired location 
and 1.0–1.5ml of the steroid and local anaesthetic 
mixture is injected. In the author’s experience, the 
outcome is fairly the same; meanwhile, in published 
literature, there is disagreement as to whether 
intraarticular injection is preferable to periarticular 
injection [39, 79–81]. 
THORACIC INTRA-ARTICULAR FACET INJECTIONS 
The orientation of the facet joints changes, 
descending along the spinal column from a coronal 
angulation in the cervical spine to a sagitally oblique 
orientation in the lower lumbar spine. At the 
thoracolumbar junction, there is a gradual change in the 
orientation of the joints, from coronal to sagittal. 
Thoracic facet joints are nearly vertical and coronal in 
orientation [44]. They are inclined nearly 60 degrees to 
the coronal plane and rotated so that the superior 
articular facet faces posteriorly, superiorly and laterally 
[76]. Hence the lateral aspect of the joint is located 
anteriorly, whereas the medial side of the joint is located 
more posteriorly. With their sagittal orientation, the 
lower thoracic facet joints more closely resemble the 
lumbar facets. 
In the thoracic spine, the basic technique and 
approach of facet joint injection is similar to that of the 
lumbar spine, with adequate concession to the 
differences in their anatomical orientation. As the medial 
aspect of the joint is more superficial and posterior, the 
needle is targeted towards it. With the patient prone, the 
point of skin entry is marked at the middle of the pedicle 
of the vertebra one level below the facet being injected 
(for example, if T6-T7 facet has to be injected, the skin 
entry site is at the middle of the pedicle of T8). Puncture 
the skin at a 60-degree angle and advance the needle 
cranially towards the target joint. The track of the needle 
is maintained between the imaginary planes along the 
lateral and medial border of the pedicle. This is to avoid 
accidental puncture of the thecal sac or lungs. Along this 
course, once the needle tip reaches the upper border of 
the pedicle, one vertebral level above the point of skin 
entry (if we consider the aforementioned example, it 
would beT7 pedicle) rotate the C-arm (almost lateral) to 
visualise the joint in profile. If the track is appropriate, 
the needle tip should be seen just below the 
posteroinferior aspect of the target joint that may be 
subsequently entered. In the thoracic spine it is 
recommended to inject a drop of contrast and confirm the 
intra-articular location of the needle, since the 
overlapping bony structures and steep angle of entry Peh Biomed Imaging Interv J 2011; 7(1):e4   8 
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makes assessment of its location difficult in plain 
fluoroscopy. 
Compared to cervical or lumbar facet injection, 
thoracic facet joint injection is technically more 
challenging; hence CT is preferred in difficult cases or in 
patients with extensive degenerative changes and spinal 
deformities. 
CERVICAL INTRA-ARTICULAR FACET INJECTIONS 
The facet joints in the cervical spine are oriented in 
an oblique coronal plane, with 35–45 degrees of 
posterior slope [44, 76]; hence, a lateral approach is 
preferred. Some interventionists use an oblique frontal 
approach. The patient is placed in a lateral position with 
the side to be injected facing upwards, shoulders drawn 
down and placed on a head rest to avoid lateral flexion of 
the neck. Once the joint is viewed in profile, it is entered 
from the posterior and inferior aspect under direct vision. 
During cervical facet injections it is most critical to avoid 
inadvertent entry into major vessels, a nerve root sheath 
or subarachnoid space. Extra care should be taken to 
ensure that the needle tip is directly positioned over the 
posterior elements on the lateral projection, avoiding in 
particular the inter-vertebral foramina and spinal canal. 
For the less experienced practitioners, frequent 
intermittent fluoroscopy in the frontal projection is 
important to check the depth of the needle. 
The same injectate is used at all the levels. However, 
the thoracic and cervical facet joints are presumably less 
capacious, as an increase in resistance to injection has 
been observed after delivering a smaller volume of the 
drug than at the lumbar facet. This is also recorded in 
published literature (56). To avoid the risk of prolonged 
effects on vital cervicomedully centres in case of an 
accidental subarachnoid injection, some operators 
preferentially use lignocaine instead of bupivacaine for 
the cervical facets. 
POST-PROCEDURE CARE AND COMPLICATIONS 
Post-procedurally, patients are routinely monitored 
for 15–20 minutes and then discharged home. The 
response to injection is recorded soon after infiltration. 
The response is recorded in the same format as in pre-
injection, using a visual analogue scale (VAS) that 
enables better quantification of the response to treatment. 
Complications are rare, particularly if the facet joint 
injection is performed using a precise needle-positioning 
technique [64, 82, 83]. Possible complications include 
spondylodiscitis [84], septic arthritis [85], and reaction to 
the injectates. Septic arthritis can be avoided with 
appropriate aseptic precautions. Severe allergic reactions 
to local anaesthetics are uncommon. Steroid injection 
may produce local reactions, occurring most often 
immediately after injection. These local reactions last for 
24–48 hours, and are relieved by application of ice packs 
[69]. Post-procedural pain flare-up may occasionally 
occur, and may be treated with NSAIDS. Transient 
numbness and paralysis, as well as paraesthesia, are 
expected to resolve within minutes to hours. Event 
transient tetraplegia after cervical facet injection has also 
been reported [86]. Other possible complications include 
vertebral artery damage during cervical entry, leakage of 
anaesthetic into the spinal canal causing motor and 
sensory blockade, phrenic palsy from overflow of local 
anaesthetic during injection at C3-C6 levels [75], 
chemical meningitis [87], epidural abscess [88], 
pneumothorax, haematoma formation, as well as 
transient ataxia and unsteadiness due to partial blockade 
of upper cervical proprioceptive afferents and the 
righting reflex from the third occipital nerve block 
during cervical injections [89, 90]. Significant vascular 
and neurological injuries are, however, extremely rare in 
image-guided injections. 
CLINICAL OUTCOME 
When performed under fluoroscopic visualisation, 
facet joint injections are accurate and clinically useful in 
the diagnosis and therapeutic management of chronic 
spinal pain. The diagnostic accuracy of facet joint blocks 
is strong for cervical and lumbar facet joints, and 
moderate for thoracic facet joints [64]. In contrast to 
clinical evaluation and imaging techniques, diagnostic 
injections can identify facet joint pain with a remarkably 
higher level of certainty [91]. However, the diagnostic 
value is limited by the high false-positive rates seen with 
single blocks (without control). False-positive rates with 
single blocks are 17%- 47% in the lumbar spine, 27%-
63% in the cervical spine, and 55%-58% in the thoracic 
spine [67, 75, 91]. There is limited literature on the 
therapeutic efficacy as most of the available data is based 
on non-controlled and observational studies. There are 
only few exhaustive randomised control trials available 
on this subject and they mostly pertain to the lumbar 
spine. Controlled studies for lumbar facet injections have 
shown initial relief of symptoms (1–4 weeks) in 42 to 
92 % of patients [81, 92], while long-term relief at three 
months varies between 18% and 62% [81, 93]; 
meanwhile uncontrolled observational studies have 
shown short-term response up to 94% [62]. In conclusion, 
for intra-articular injection of local anaesthetics and 
steroids, there is moderate evidence of short-term relief 
and limited evidence of long-term relief of chronic neck 
and low back pain [41]; meanwhile a recent systematic 
review failed to provide any evidence or 
recommendation with respect to the therapeutic value of 
intra-articular facet joint injections in the thoracic spine 
[94]. 
The evidence of intra-articular injections of local 
anaesthetics and steroids from randomised trials, 
complemented with that of non-randomised trials 
(prospective and retrospective evaluations), provided 
moderate evidence of short-term relief and limited 
evidence of long-term relief of chronic neck and low 
back pain. Peh Biomed Imaging Interv J 2011; 7(1):e4   9 
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